What Does A Real MDMA Therapy Session Look Like?
Published: June 6th, 2025
A Basic Guide Based On The MAPS Protocol
MDMA-assisted therapy is rapidly emerging as one of the most promising new treatments for PTSD and trauma-related conditions. Built on nearly two decades of research led by the Multidisciplinary Association for Psychedelic Studies (MAPS), this therapy combines the powerful effects of MDMA with structured psychotherapy to facilitate deep emotional healing.
In this blog, we’ll walk you through exactly what a real MDMA therapy session looks like — step by step — based on the MAPS clinical protocols.
Understanding MDMA-Assisted Therapy
MDMA (3,4-methylenedioxymethamphetamine) has unique properties: it reduces fear and defensiveness, while enhancing feelings of trust, empathy, and emotional insight. These effects create a powerful therapeutic window that allows patients to revisit and process painful memories without becoming overwhelmed.
Dr. Michael Mithoefer, one of the lead researchers for MAPS Phase 3 clinical trials, notes: “MDMA doesn’t do the work for the patient.
It makes it easier for them to do the work themselves.” (Source: MAPS.org)
The Three Core Phases Of MDMA Therapy
MDMA-assisted therapy typically unfolds across three critical phases: Preparation, Dosing, and Integration.
1. Preparation Phase
Sessions: Patients engage in 2–3 preparatory sessions with their therapists (often a male/female team) before ever taking MDMA.
Goals: Build trust, understand the patient’s trauma history, set therapeutic intentions, and establish emotional safety.
Format: These are standard talk-therapy sessions lasting approximately 90 minutes each.
Key Insight: Research shows that the quality of the therapeutic relationship is one of the strongest predictors of treatment success. (Source: MAPS Pivotal Trials, 2021)
2. MDMA Dosing Sessions
Number of Sessions: Patients typically have 2–3 MDMA-assisted sessions, each spaced roughly one month apart.
Dosage: The first dose ranges between 80–120 mg of MDMA, with an optional supplemental dose of 40–60 mg administered 1.5–2 hours later to prolong the therapeutic window.
Setting: Sessions are held in a comfortable, non-clinical environment, with two trained therapists present at all times.
Duration: Each dosing session typically lasts 6–8 hours, allowing for deep, unhurried emotional processing. Many trials also include an overnight stay for continued support.
Experience: Patients may alternate between talking, silently reflecting, listening to specially curated music, and moving through waves of emotion. Therapists provide gentle support without steering the experience.
Key Insight: Dr. Rick Doblin, founder of MAPS, emphasizes: “The healing comes from within the patient. The MDMA helps remove the fear barrier so they can confront and work through their trauma.”
3. Integration Phase
Sessions: Following each MDMA session, patients complete 2–3 integration therapy sessions.
Goals: Process the experiences from the MDMA session, make sense of emotional insights, and apply new understanding to daily life.
Timing: The first integration session usually occurs the day after the MDMA session, with others scheduled weekly.
Key Insight: Integration is critical. As MAPS clinical psychologist Dr. Annie Mithoefer explains: “Without integration, the breakthroughs of MDMA sessions can remain isolated events rather than truly transformative experiences.”
Why This Matters
MDMA-assisted therapy is not about the drug alone, it’s about creating the right conditions for profound emotional healing. As shown in the MAPS Phase 3 trials, 67% of participants no longer qualified for a PTSD diagnosis just two months after completing treatment.
This represents a potential breakthrough not just for PTSD, but for a range of trauma-related conditions that conventional treatments often fail to address.
Stay Connected
Stay updated on PSYCADEMY’s psychedelic updates—sign up for our newsletter!
You can unsubscribe at anytime.